drugset / Trial / NCT00653757

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

NCT00653757

Phase 1/2 Completed 100 enrolled Mayo Clinic National Cancer Institute (NCI) · collab
Open-labelTreatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Using scintigraphy to plan specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the side effects and best way to give intensity-modulated radiation therapy and to see how well it works in treating patients with stage I, stage II, stage III, or stage IV prostate cancer.

Timeline

Start
2002-03
Primary completion
2006-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified Subcutaneous
Subject Leuprolide Other / unclassified Intramuscular

Indications